Herd protection against influenza
| Autor: | W. Paul Glezen |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
Adult
Immunity Herd Pediatrics medicine.medical_specialty Influenza vaccine Population Vaccines Attenuated Rubella Herd immunity Virology Influenza Human Humans Medicine Live attenuated influenza vaccine education education.field_of_study business.industry Hepatitis A medicine.disease Community-Acquired Infections Vaccination Infectious Diseases Influenza Vaccines Child Preschool Immunology Human mortality from H5N1 business |
| Zdroj: | Journal of Clinical Virology. 37:237-243 |
| ISSN: | 1386-6532 |
| DOI: | 10.1016/j.jcv.2006.08.020 |
| Popis: | Mortality and hospitalization rates due to influenza have risen despite increasing vaccine coverage for the most vulnerable population; however, those most vulnerable to complications and death are the least likely to respond to the vaccine. New strategies for influenza control are needed and indirect effectiveness (herd protection) has been demonstrated for several currently used vaccines - rubella, H. influenzae type b, pneumococcus varicella and hepatitis A. The Japanese schoolchildren program provided proof of concept of indirect effectiveness of influenza vaccine. The Central Texas field trial has demonstrated significant herd protection of adults utilizing the live, attenuated influenza vaccine (LAIV) to children. Immunization of |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect